SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Munoz Jules Ricardo (Last) (First) (Middle) 1000 STANLEY DRIVE (Street) NEW BRITAIN CONNECTICUT 06053 (City) (State) (Zip) UNITED STATES (Country)	2. Date of Event Requiring Statement (Month/Day/Year) 08/10/2026	3. Issuer Name and Ticker or Trading Symbol STANLEY BLACK & DECKER, INC. [ SWK ]
		3a. Foreign Trading Symbol	5. If Amendment, Date of Original Filed (Month/Day/Year)
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP, Global CETO	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,146	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	03/01/2034	Common Stock	8,168	$89.34	D
Stock Option (Right to Buy)	(2)	02/21/2035	Common Stock	8,022	$89.005	D
Stock Option (Right to Buy)	(3)	02/27/2036	Common Stock	9,208	$85.9	D
Restricted Stock Units	(4)	(4)	Common Stock	3,130	(5)	D
Restricted Stock Units	(6)	(6)	Common Stock	1,544	(5)	D
Restricted Stock Units	(7)	(7)	Common Stock	770	(5)	D
Restricted Stock Units	(8)	(8)	Common Stock	2,401	(5)	D

Explanation of Responses:

1. The option is exercisable in three approximately equal annual installments beginning on March 1, 2025.

2. The option is exercisable in three approximately equal annual installments beginning on February 21, 2026.

3. The option will become exercisable in three approximately equal annual installments beginning on February 27, 2027.

4. The Restricted Stock Units ("RSUs") were granted on December 19, 2023, and the 3,130 outstanding RSUs will vest on December 19, 2026.

5. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

6. The RSUs were granted on February 21, 2025, and the 1,544 outstanding RSUs will vest in two approximately equal annual installments on February 21, 2027, and February 21, 2028.

7. The RSUs were granted on March 1, 2024, and the 770 outstanding RSUs will vest on March 1, 2027.

8. The RSUs were granted on February 27, 2026, and will vest in three approximately equal annual installments beginning on February 27, 2027.

Remarks:

	/s/ Donald J. Riccitelli, Attorney-in-Fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)